SOLARA ACTIVE PHARMA SCIENCES LIMITED — Capital/Financing Update 2025

Mar 20, 2025

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : investors@solara.co.in www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

March 20, 2025

The BSE Limited

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540, 890202

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Scrip Code: SOLARA, SOLARAPP

Dear Sir / Madam,

Sub: Announcement of Rights Issue Committee Meeting under Regulation 29 (1) of SEBI Listing Regulations

This is to inform you that a meeting of Rights Issue Committee of the Board of Directors of the Company is scheduled to be held on Wednesday, March 26, 2025, inter alia:

• a) To consider and approve, a proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, having a face value of Rs.10/- each (Rs.3.50/- paid-up) issued by the Company on rights basis in accordance with the Letter of Offer dated May 09, 2024.

• b) Any other matters, which may be incidental and ancillary to making aforesaid first call.

This is for your information and appropriate dissemination.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2025.03.20 14:55:11 +05'30' S. Murali Krishna Company Secretary Membership No: A13372

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942